An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer.

por Munro, A. J.
Publicado 1995

A Case of Moral Insanity

por Munro, A. C.
Publicado 1878

Athetosis

por Munro, A. C.
Publicado 1878

A Peculiar Pigmentary Condition

por Munro, A. Campbell
Publicado 1911

Dengue-Like Fevers

por Munro, A. Campbell
Publicado 1911

Measles: An Epidemiological Study

por Munro, A. Campbell
Publicado 1891

A quantitative approach to the distress caused by symptoms in patients treated with radical radiotherapy.

por Munro, A. J., Potter, S.
Publicado 1996

What is a virtual multidisciplinary team (vMDT)?

por Munro, A J, Swartzman, S
Publicado 2013

The management of testicular seminoma: Edinburgh 1970-1981.

por Duncan, W., Munro, A. J.
Publicado 1987

Opportunity cost--a neglected aspect of cancer treatment.

por Munro, A. J., Sebag-Montefiore, D.
Publicado 1992

P53 abnormalities and outcomes in colorectal cancer: a systematic review

por Munro, A J, Lain, S, Lane, D P
Publicado 2005

ANTIGEN-SPECIFIC T-CELL FACTOR IN CELL COOPERATION: PHYSICAL PROPERTIES AND MAPPING IN THE LEFT-HAND (K) HALF OF H-2

por Munro, A. J., Taussig, M. J., Campbell, Rosalie, Williams, Heather, Lawson, Yvonne
Publicado 1974

Distress associated with radiotherapy for malignant disease: a quantitative analysis based on patients perceptions.

por Munro, A. J., Biruls, R., Griffin, A. V., Thomas, H., Vallis, K. A.
Publicado 1989

Chromosome instability and benefit from adjuvant anthracyclines in breast cancer

por Munro, A F, Twelves, C, Thomas, J S, Cameron, D A, Bartlett, J MS
Publicado 2012

Characteristics of patients dying within 30 days of diagnosis of breast or colorectal cancer in Scotland, 2003–2007

por Brewster, D H, Clark, D I, Stockton, D L, Munro, A J, Steele, R J C
Publicado 2011

Late effects of treatment for early-stage Hodgkin's disease.

por Brierley, J. D., Rathmell, A. J., Gospodarowicz, M. K., Sutcliffe, S. B., Munro, A., Tsang, R., Pintilie, M.
Publicado 1998

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas

por Aubele, M, Auer, G, Walch, A K, Munro, A, Atkinson, M J, Braselmann, H, Fornander, T, Bartlett, J M S
Publicado 2007

An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta H...

por Munro, A. J., Nielsen, O. S., Duncan, W., Sturgeon, J., Gospodarowicz, M. K., Malkin, A., Thomas, G. M., Jewett, M. A.
Publicado 1991

Antibody-guided irradiation of malignant pleural and pericardial effusions.

por Pectasides, D., Stewart, S., Courtenay-Luck, N., Rampling, R., Munro, A. J., Krausz, T., Dhokia, B., Snook, D., Hooker, G., Durbin, H.
Publicado 1986

A low pH enzyme linked immunoassay using two monoclonal antibodies for the serological detection and monitoring of breast cancer.

por Dhokia, B., Pectasides, D., Self, C., Habib, N. A., Hershman, M., Wood, C. B., Munro, A. J., Epenetos, A. A.
Publicado 1986